Inclusive clinical research does not begin with a protocol. If we want clinical trials to contribute to health equity, we need to move from engagement as an administrative step to partnership as the core method.

Biotechnology is shifting from a specialist discipline to the foundation of every sector. For life sciences professionals, this is not a distant future. It is an immediate change in how we think, work and create impact.

South Korea has quietly but decisively positioned itself as one of the world’s leading destinations for clinical research

Risk Management Plans (RMPs) sit at the heart of post-market safety oversight for medicines. Yet despite being well established within regulatory frameworks, they continue to appear regularly in inspection findings.

Breakthrough cell and gene therapies are redefining what is medically possible. Yet in Australia, reimbursement and delivery systems built for conventional medicines are struggling to keep pace, leaving patients waiting years for life-saving treatments.

Resilience is often spoken about as an individual trait. In reality, it is a collective discipline. Drawing on lessons from elite team sport, Australian national handball coach Tomek Szklarski demonstrates how leadership, trust and culture determine whether teams fracture under pressure or rise together.

Elaine Blair has been part of the ARCS community for more than two decades, contributing not only as a long-standing member but also as an active volunteer.

The MTP Sector Awards are ARCS’ highest recognition of excellence

As the life sciences sector becomes increasingly interconnected, cultural competence is no longer a ‘nice to have’ it is a critical leadership skill.

As professionals transition into leadership roles, the ability to influence, adapt, and lead through complexity becomes paramount.

Understanding neuroscience provides a framework for improving these aspects of ourselves

Clinical trials are central to advancing healthcare, yet their journey is rarely smooth.